Trial · NCT02275780
Participant flow26
How many started, completed or left each group, period by period.
1 to 20 of 26
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Base Study: 96 Weeks | STARTED | Doravirine 100 mg | 385 | |
| Base Study: 96 Weeks | STARTED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 384 | |
| Base Study: 96 Weeks | Treated | Doravirine 100 mg | 383 | |
| Base Study: 96 Weeks | Treated | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 383 | |
| Base Study: 96 Weeks | COMPLETED | Doravirine 100 mg | 292 | |
| Base Study: 96 Weeks | COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 273 | |
| Base Study: 96 Weeks | NOT COMPLETED | Doravirine 100 mg | 93 | |
| Base Study: 96 Weeks | NOT COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 111 | |
| Study Extension 1: Week 96 to Week 192 | STARTED | Doravirine 100 mg | 259 | |
| Study Extension 1: Week 96 to Week 192 | STARTED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 233 | |
| Study Extension 1: Week 96 to Week 192 | COMPLETED | Doravirine 100 mg | 210 | |
| Study Extension 1: Week 96 to Week 192 | COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 190 | |
| Study Extension 1: Week 96 to Week 192 | NOT COMPLETED | Doravirine 100 mg | 49 | |
| Study Extension 1: Week 96 to Week 192 | NOT COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 43 | |
| Study Extension 2: Week 192 to Week 288 | STARTED | Doravirine 100 mg | 148 | |
| Study Extension 2: Week 192 to Week 288 | STARTED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 129 | |
| Study Extension 2: Week 192 to Week 288 | COMPLETED | Doravirine 100 mg | 101 | |
| Study Extension 2: Week 192 to Week 288 | COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 91 | |
| Study Extension 2: Week 192 to Week 288 | NOT COMPLETED | Doravirine 100 mg | 47 | |
| Study Extension 2: Week 192 to Week 288 | NOT COMPLETED | Daurunavir 800 mg + Ritonavir 100 mg → Doravirine 100 mg | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02275780/flow